Anticancer agent 380
Anticancer agent 380 is an anticancer agent that induces PANoptosis. Anticancer agent 380 increases the expression of the pyroptosis-related inflammasome sensor NLRP3, the BAX/BCL2 expression ratio, the cleavage and activation of caspase-3, the generation of the GSDME N-terminal fragment, and the phosphorylation of MLKL. Anticancer agent 380 induces G2/M cell cycle arrest and inhibits colony formation and cell migration. Anticancer agent 380 is a dual-responsive fluorescent probe for pH and viscosity and can be used for intracellular imaging. Anticancer agent 380 can be used for research on hepatocellular carcinoma.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 2988881-33-8
- Formel: C24H21N3O2
- Molecular Weight:383.44
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle Caspase Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
NLRP3 |
Bax |
BCL2 |
Caspase 3 |
GSDME |
MLKL |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HepG2 | IC50 |
7.18 μM
|
Cytotoxicity against human HepG2 cells assessed as viability reduction incubated 48 hrs by MTS assay.
Cytotoxicity against human HepG2 cells assessed as viability reduction incubated 48 hrs by MTS assay.
|
42700738 |
| SMMC-7721 | IC50 |
14.08 μM
|
Cytotoxicity against human SMMC-7721 cells assessed as viability reduction incubated 48 hrs by MTS assay.
Cytotoxicity against human SMMC-7721 cells assessed as viability reduction incubated 48 hrs by MTS assay.
|
42700738 |
| Bel-7402 | IC50 |
9.24 μM
|
Cytotoxicity against human Bel-7402 cells assessed as viability reduction incubated 48 hrs by MTS assay.
Cytotoxicity against human Bel-7402 cells assessed as viability reduction incubated 48 hrs by MTS assay.
|
42700738 |
| HSC-T6 | IC50 |
11.39 μM
|
Cytotoxicity against HSC-T6 cells assessed as viability reduction incubated 48 hrs by MTS assay.
Cytotoxicity against HSC-T6 cells assessed as viability reduction incubated 48 hrs by MTS assay.
|
42700738 |
In Vitro
Anticancer agent 380 (5-20 µM; 24 h) inhibits colony formation in HepG2 and Bel-7402 hepatocellular carcinoma cells in a concentration-dependent manner[1].
Anticancer agent 380 (5-20 µM; 48 h) inhibits the migration of HepG2 and Bel-7402 hepatocellular carcinoma cells in a concentration-dependent manner[1].
Anticancer agent 380 (5-20 µM; 48 h) induces apoptosis in HepG2 cells, with total apoptotic cells reaching 19.75% at 20 µM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HepG2 and Bel-7402 cells
-
Concentration:5, 10, 20 µM
-
Incubation Time:24 h
-
Result:Inhibited colony formation in HepG2 and Bel-7402 hepatocellular carcinoma cells in a concentration-dependent manner.
-
Cell Line:HepG2 and Bel-7402 cells
-
Concentration:5, 10, 20 µM
-
Incubation Time:48 h
-
Result:Cell migration was inhibited in both HepG2 and Bel-7402 cells, with increased wound width and reduced healing rate at 5, 10, and 20 µM compared with the control.
-
Cell Line:HepG2 cells
-
Concentration:5, 10, 20 µM
-
Incubation Time:48 h
-
Result:Induced G2/M cell cycle arrest in HepG2 cells.
-
Cell Line:HepG2 cells
-
Concentration:5, 10, 20 µM
-
Incubation Time:24 h
-
Result:With increasing concentration from 5 µM to 20 µM, blue fluorescence was enhanced and the number of apoptotic cells increased.
The total apoptotic cell proportion increased to 19.75% at 20 µM.
-
Cell Line:HepG2 cells
-
Concentration:5, 10, 20 µM
-
Incubation Time:48 h
-
Result:BCL2 decreased and BAX increased, increasing the BAX/BCL2 ratio.
Cleaved caspase-3 increased, GSDME was cleaved to GSDME-N, NLRP3 increased, and MLKL phosphorylation increased in a concentration-dependent manner.
- RNA extraction experimental
- Western Blot
- Scratch/Wound-Healing Migration Assay
- BrdU Incorporation Assay
- Cell migration
- Neural Crest/Neuronal Cell Migration Explant Assay
- Protocol for Cell Cycle
- Liver Cancer Modeling
- Colony Formation (Clonogenic) Assay
- Kinase activity and phosphorylation assays
- Flow cytometric DNA-content cell-cycle staining
- Zigmond Chamber Chemotaxis Assay
- Under-Agarose Cell Migration Assay
- Transwell/Boyden Chamber Migration Assay
- Apoptosis Solutions
- 3D Collagen/Hydrogel Matrix Migration Assay
- Protocol for Kinase activity and phosphorylation assays
- Soft Agar Colony Formation Assay
- Cell-Exclusion Zone Migration Assay
- Dunn/Insall Chamber Chemotaxis Assay
- Pyroptosis Solutions
Chemical Information
-
CAS. Nr. 2988881-33-8
-
Molecular Weight 383.44
-
Formel C24H21N3O2
-
SMILES
O=C(C1=CC=C2NC(C3=CC4=C(C=C3)N(CC)C5=C4C=CC=C5)=NC2=C1)OCC
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Keywords
- Anticancer agent 380
- 2988881-33-8
- Anticancer agent380
- Anticancer agent-380
- NOD-like Receptor (NLR)
- Bcl-2 Family
- Caspase
- Mixed Lineage Kinase
- PANoptosis
- Pyroptosis
- MLKs
- G2/M cell cycle arrest
- GSDME
- MLKL phosphorylation
- NLRP3 inflammasome
- apoptosis
- hepatocellular carcinoma
- necroptosis
- pyroptosis
- reactive oxygen species
- Inhibitor
- inhibitor
- inhibit